Carbidopa Anhydrous en es it fr

Carbidopa Anhydrous Brand names, Carbidopa Anhydrous Analogs

Carbidopa Anhydrous Brand Names Mixture

  • Atamet (carbidopa + levodopa)
  • Sinemet (carbidopa + levodopa)

Carbidopa Anhydrous Chemical_Formula

C10H14N2O4

Carbidopa Anhydrous RX_link

http://www.rxlist.com/cgi/generic/sinemet.htm

Carbidopa Anhydrous fda sheet

Carbidopa Anhydrous msds (material safety sheet)

Carbidopa Anhydrous Synthesis Reference

Chemerda et al., U.S. Pat. 3,462,536 (1963)

Carbidopa Anhydrous Molecular Weight

226.229 g/mol

Carbidopa Anhydrous Melting Point

203-205oC

Carbidopa Anhydrous H2O Solubility

3.8 mg/L

Carbidopa Anhydrous State

Solid

Carbidopa Anhydrous LogP

0.494

Carbidopa Anhydrous Dosage Forms

Tablet (25 mg)

Carbidopa Anhydrous Indication

For treatment of the symptoms of idiopathic Parkinson's disease (paralysis agitans), post-encephalitic parkinsonism

Carbidopa Anhydrous Pharmacology

Carbidopa, a noncompetitive decarboxylase inhibitor, is used in combination with levodopa for the treatment of Parkinson's disease.

Carbidopa Anhydrous Absorption

Rapidly decarboxylated to dopamine in extracerebral tissues so that only a small portion of a given dose is transported unchanged to the central nervous system.

Carbidopa Anhydrous side effects and Toxicity

Symptoms of a carbidopa toxicity include muscle spasms or weakness, spasms of the eyelid, nausea, vomiting, diarrhea, an irregular heartbeat, confusion, agitation, hallucinations, and unconsciousness.

Carbidopa Anhydrous Patient Information

Carbidopa is used with levodopa to treat Parkinson's disease. Parkinson's disease
is believed to be related to low levels of a chemical called dopamine (DOE pa meen)
in the brain. Levodopa (Dopar, Larodopa) is turned into dopamine in the body.
Carbidopa is used with levodopa to prevent the breakdown (metabolism) of levodopa
before it can reach the brain and take effect. Carbidopa is only effective if it is
taken with levodopa. It has no effect if it is used alone. Carbidopa is used with
levodopa to treat the stiffness, tremors, spasms, and poor muscle control of
Parkinson's disease. These medications are also used to treat the same muscular
conditions when they are caused by drugs such as chlorpromazine (Thorazine),
fluphenazine (Prolixin), perphenazine (Trilafon), and others.

Carbidopa Anhydrous Organisms Affected

Humans and other mammals